FHIT and cervical carcinoma: Loss of heterozygosity in 3p and reduced FHIT expression have been reported in cervical cancer and precancer lesions (Wistuba et al, 1997; Birrer et al, 1999; Chung et al, 2000; Connolly et al, 2000; Guo et al, 2001; Acevedo et al, 2002) but, because of small sample numbers or because of differences in the 3p loci selected for LOH analysis, it is not clear if any regions of 3p are consistently deleted or if reduction in FHIT protein level is dependent on these deletions.